Compare Medtronic PLC (MDT) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs NEOS S&P 500 High Income ETF — how do they compare? Medtronic PLC trades at $82.63 (market cap $106.61B), while NEOS S&P 500 High Income ETF trades at $52.95. The key difference: Medtronic PLC pays a 3.46% dividend while NEOS S&P 500 High Income ETF pays none, and NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | SPYI | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $105.35 | $54.07 |
52-Week Low | $73.75 | $47.98 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
SPYI (NEOS S&P 500 High Income ETF) trades at $53.01, down 0.11% with a bearish technical signal. The fund has grown to over $10 billion in assets under management and delivers consistent monthly distributions through its covered call strategy. Recent performance shows 8% year-to-date and 19% one-year returns, though trailing the broader S&P 500. The ETF's two-leg options strategy enables robust income generation while retaining partial upside exposure.
SPYI offers investors high-yield income with downside protection, making it attractive for retirement portfolios. However, the fund's 0.68% expense ratio and potential return of capital distributions require careful consideration. Market volatility benefits the options strategy, but sustained bull markets may limit upside participation compared to traditional index funds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About NEOS S&P 500 High Income ETF
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →
